- BiondVax Pharmaceuticals Ltd. (BVXV): Important & Key Factors of Healthcare Stock
- What's the Analyst Recommendation for iHeartMedia Inc. (IHRT)?
- Let’s Take a Look at Milestone Pharmaceuticals Inc. (MIST) Stock
- Is it Time to Sell/Buy United States Steel Corporation (X) Stock After Recent Trade?
- Aptose Biosciences Inc. (APTO) is down -10.05% this year
Citigroup announced it was Initiated coverage of Eros International Plc in a research note on August 14, 2018. The analysts assigned a Buy rating to the stock. Wells Fargo rated the stock as an Outperform in a research noted published on December 09, 2016. BofA/Merrill rated the stock as a Neutral in a research note published on November 24, 2015.
EROS Recent Trade
The share price of EROS descended by -$0.69 during the exchanging session on 07/30/20 to exchange at $3.11. Eros International Plc stock has an exchanging volume of 14.93 million shares, which is high, contrasted with its 3-months average volume of 3.65M shares. Its market capitalization has now reached to $414.38M and analysts have a consensus target price of $4.50 in the 12-month period.
EROS Past Trading Activity
The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, EROS price has dropped by -11.90%. In the course of past three months sees the stock go up around 21.96%, while it has gain 13.50% over the past six months and -8.26% since the start of the year.
EROS Earning History
Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Sep 2020), the firm recorded a revenue of 50.75 billion, which was higher than the gauge of 37.23M made by certain experts. For that equivalent quarter, Eros International Plc posted -$0.15 earnings per share (EPS) which was underneath the consensus estimate of $0.07 by -$0.22, which represents to a reduction by -314.30%.
EROS Price Performance
Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Eros International Plc has seen its stock exchanging -25.06% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +34.63% above its three-month low. A more extensive look sees EROS exchanging -36.66% beneath its 52-week high and 182.73% above from its 52-week low price.
EROS Instability & Beta Factor
The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 11.24%, while it has a month to month instability of 10.35%. Ticker has an ATR (Average True Range) of 0.32 and a beta factor of 1.16.